Clinical Trials Browser

Active not recruiting × Interventional × Antibodies, Monoclonal × Clear all

NCT04262466 2026-03-06

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Phase 1/2 Active not recruiting

Other solid neoplasm

Select Advanced Solid Tumors

NCT03942224 2024-06-21

DeRIVE

Phase 2 Active not recruiting

Multiple Myeloma